These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32872058)

  • 1. Myopathy is a Risk Factor for Poor Prognosis of Patients with Systemic Sclerosis: A retrospective cohort study.
    Zhou M; Jiang L; Nie L; Chen T; Zhang T; Sun W; Sutikno J; Du Y; Xue J
    Medicine (Baltimore); 2020 Aug; 99(33):e21734. PubMed ID: 32872058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
    Jung M; Bonner A; Hudson M; Baron M; Pope JE;
    Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality.
    Paik JJ; Wigley FM; Shah AA; Corse AM; Casciola-Rosen L; Hummers LK; Mammen AL
    Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1764-1770. PubMed ID: 28544788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory features of scleroderma patients developing skeletal myopathy.
    Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
    Clin Rheumatol; 2005 Apr; 24(2):99-102. PubMed ID: 15322944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.
    Hu S; Hou Y; Wang Q; Li M; Xu D; Zeng X
    Arthritis Res Ther; 2018 Oct; 20(1):235. PubMed ID: 30348207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.
    Guillen-Del Castillo A; Pilar Simeón-Aznar C; Fonollosa-Pla V; Alonso-Vila S; Reverte-Vinaixa MM; Muñoz X; Pallisa E; Selva-O'allaghan A; Fernández-Codina A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2014 Dec; 44(3):331-7. PubMed ID: 25110305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality.
    Champtiaux N; Cottin V; Chassagnon G; Chaigne B; Valeyre D; Nunes H; Hachulla E; Launay D; Crestani B; Cazalets C; Jego P; Bussone G; Bérezné A; Guillevin L; Revel MP; Cordier JF; Mouthon L;
    Semin Arthritis Rheum; 2019 Aug; 49(1):98-104. PubMed ID: 30409416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.
    Simeon CP; Armadans L; Fonollosa V; Vilardell M; Candell J; Tolosa C; Mearin F; Rodrigo MJ; Solans R; Lima J; Sampol G
    Ann Rheum Dis; 1997 Dec; 56(12):723-8. PubMed ID: 9496151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association.
    Follansbee WP; Zerbe TR; Medsger TA
    Am Heart J; 1993 Jan; 125(1):194-203. PubMed ID: 8417518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with Systemic Sclerosis/polymyositis Overlap Have a Worse Survival Rate Than Patients Without It.
    Bhansing KJ; van Riel PL; van Engelen BG; Fransen J; Vonk MC
    J Rheumatol; 2016 Oct; 43(10):1838-1843. PubMed ID: 27528573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First pilot study of extracellular volume MRI measurement in peripheral muscle of systemic sclerosis patients suggests diffuse fibrosis.
    Dumitru RB; Goodall AF; Broadbent DA; Del Galdo F; Tan AL; Biglands JD; Buch MH
    Rheumatology (Oxford); 2022 Apr; 61(4):1651-1657. PubMed ID: 34273164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical importance of gastroesophageal reflux in Chinese patients with systemic sclerosis.
    Liu X; Li M; Xu D; Hou Y; Wang Q; Tian Z; Sun Q; Zeng X
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S60-6. PubMed ID: 22691211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
    Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
    J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
    Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG
    Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.